Author Jeremy Levin discusses how various factors are impacting the biotech industry in a negative way by pushing investment and politics over science.
Dr. Jeremy Levin
Advertisement
Articles by Dr. Jeremy Levin
Dr. Jeremy Levin discusses the mismatch between capital markets and biotech and how the industry doesn’t provide the results that investors are often looking for.
Dr. Jeremy Levin explains how the current media environment allows for misinformation spread, and the impact it has on trust in medicine.
Dr. Jeremy Levin discusses the importance of relying on scientific fact to make decisions in biotech research.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Xocova as First Oral Post-Exposure Covid-19 Prevention Therapy
2
Pharma M&A Roundup: Servier Acquiring Edgewise Therapeutics' Muscular Dystrophy Business, Hanmi Enters Licensing Agreement with Eli Lilly, Avenzo Enters Merger Agreement with Rallybio
3
Why Breakthrough Cell and Gene Therapies Still Fail at the Finish Line
4
CVS Restores Coverage of Lilly’s Zepbound, Adds Oral Obesity Drug Foundayo
5